Ray Dalio United Therapeutics Corp Transaction History

Bridgewater Associates, LP

$20.7 Billion
Q1 2025

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in United Therapeutics Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 193,784 shares of UTHR stock, worth $62 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

193,784

Previous 107,730 79.88%

Holding current value

$62 Million

Previous $38 Million 57.16%

% of portfolio

0.29%

Previous 0.18%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$304.42 - $380.78 $26.2 Million - $32.8 Million	86,054 Added 79.88%	193,784 $59.7 Million
Q4 2024 Feb 13, 2025	BUY	$348.66 - $410.0 $16 Million - $18.8 Million	45,975 Added 74.45%	107,730 $38 Million
Q3 2024 Nov 13, 2024	BUY	$311.04 - $363.55 $15.2 Million - $17.8 Million	49,003 Added 384.28%	61,755 $22.1 Million
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $1.1 Million - $1.53 Million	4,802 Added 60.4%	12,752 $4.06 Million
Q1 2024 May 14, 2024	SELL	$210.76 - $249.51 $225,302 - $266,726	-1,069 Reduced 11.85%	7,950 $1.83 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $1.96 Million - $2.35 Million	-9,128 Reduced 50.3%	9,019 $1.98 Million
Q3 2023 Nov 13, 2023	SELL	$211.82 - $248.24 $4.8 Million - $5.62 Million	-22,658 Reduced 55.53%	18,147 $4.1 Million
Q2 2023 Aug 11, 2023	SELL	$205.19 - $232.99 $94,387 - $107,175	-460 Reduced 1.11%	40,805 $9.01 Million
Q1 2023 May 12, 2023	BUY	$212.99 - $276.17 $3.44 Million - $4.46 Million	16,161 Added 64.38%	41,265 $9.24 Million
Q4 2022 Feb 13, 2023	SELL	$205.95 - $280.43 $3.94 Million - $5.36 Million	-19,113 Reduced 43.23%	25,104 $6.98 Million
Q3 2022 Nov 10, 2022	SELL	$203.3 - $244.17 $2.08 Million - $2.49 Million	-10,209 Reduced 18.76%	44,217 $9.26 Million
Q2 2022 Aug 11, 2022	BUY	$174.81 - $241.14 $9.51 Million - $13.1 Million	54,426 New	54,426 $12.8 Million
Q2 2019 Aug 13, 2019	SELL	$76.06 - $120.81 $693,971 - $1.1 Million	-9,124 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$107.15 - $126.84 $977,636 - $1.16 Million	9,124 New	9,124 $1.07 Million
Q4 2018 Feb 13, 2019	SELL	$101.4 - $128.73 $5.45 Million - $6.92 Million	-53,726 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$113.81 - $129.46 $956,117 - $1.09 Million	8,401 Added 18.54%	53,726 $6.87 Million
Q2 2018 Aug 13, 2018	SELL	$101.14 - $118.31 $11.7 Million - $13.7 Million	-116,024 Reduced 71.91%	45,325 $0
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $7.25 Million - $10.3 Million	67,626 Added 72.16%	161,349 $18.1 Million
Q4 2017 Feb 13, 2018	BUY	$118.58 - $151.28 $113,006 - $144,169	953 Added 1.03%	93,723 $13.9 Million
Q3 2017 Nov 13, 2017	BUY	$114.6 - $136.81 $10.6 Million - $12.7 Million	92,770	92,770 $10.9 Million

Others Institutions Holding UTHR

# of Institutions

733

Shares Held

43.6M

Call Options Held

124K

Put Options Held

122K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account